AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
18:55
Radu Miruță is asking Grindeanu to include on the agenda the USR project that prohibits the closure of energy production capacities without alternatives.
18:54
A man was accused of blackmail after he demanded 600,000 euros from his former employer, threatening that he would shoot his son if he did not receive the money.
18:45
The Russian embassy in Italy accused Ukraine of the bombing attack at a restaurant in Moscow, which resulted in five deaths and 19 injuries.
18:39
The Ministry of Foreign Affairs informs Romanian citizens that the land border between Latvia and Belarus is closed.
18:33
Ursula von der Leyen has called for increased measures to strengthen the EU's borders, following the migration crisis in Ceuta.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
